Regular articleVascular biology, atherosclerosis, and endothelium biologyProstaglandin Receptor EP4 in Abdominal Aortic Aneurysms
Vascular biology, atherosclerosis, and endothelium biology
Under an Elsevier user license
open archive
Cited by (0)
Supported by a grant from the Canadian Institutes of Health Research (MOP-93689 to C.D.F.). C.D.F. is the recipient of a Tier I Canada Research Chair in Molecular, Cellular and Physiological Medicine and is a Career Investigator of the Heart and Stroke Foundation of Ontario.
Disclosures: T.M. is employed by Ono Pharmaceutical Co., Ltd., which supplied the EP4 antagonist, AE3-208, used in these studies.
Supplemental material for this article can be found on http://ajp.amjpathol.org or at http://dx.doi.org/10.1016/j.ajpath.2012.03.016.
Copyright © 2012 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.